Tango Therapeutics TNGX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.19M-15.2% | $5.63M-28.6% | $5.76M-30.7% | $6.48M-22.7% | $7.31M-5.8% | ||
| $56.99M+39.0% | $62.38M+48.3% | $66.5M+53.3% | $24.3M-42.8% | $40.99M+10.1% | ||
| $129.26M-9.2% | $132.17M-8.2% | $134M-5.2% | $136.45M+0.9% | $142.3M+13.6% | ||
| $174.52M-6.6% | $173.67M-7.5% | $176.84M-3.4% | $181.58M+3.8% | $186.86M+14.4% | ||
| $174.52M-6.6% | $173.67M-7.5% | $176.84M-3.4% | $181.58M+3.8% | $186.86M+14.4% | ||
| $10.27M-25.6% | $9.7M-37.4% | $9.93M-39.9% | $11.89M-26.3% | $13.81M-5.8% | ||
| -$107.23M+18.9% | -$101.59M+22.0% | -$100.52M+18.5% | -$145.57M-25.0% | -$132.26M-18.5% | ||
| -188.2%+135pp | -162.9%+147pp | -151.1%+133pp | -599.1%-325pp | -322.7%-22.8pp | ||
| -$0.83+31.4% | -$0.87+27.5% | -$0.91+21.6% | -$1.32-17.9% | -$1.21-9.0% | ||
| 481.2M+10.3% | 448M+3.2% | 441M+5.1% | 438.6M+7.5% | 436.3M+12.4% | ||
| -$107.54M+18.4% | -$101.71M+21.9% | -$101.14M+17.1% | -$145.14M-25.9% | -$131.81M-20.2% | ||
| $6.19M-15.2% | $5.63M-28.6% | $5.76M-30.7% | $6.48M-22.7% | $7.31M-5.8% | ||
| $302.34M+6,355% | $222.5M+367% | $4.09M-91.5% | $3.95M-96.9% | $4.68M-96.3% | ||
| -$61.83M-148% | -$40.87M-147% | $146.91M+116% | $132.01M— | $127.93M— | ||
| -$141.55M-4.6% | -$138.89M-5.6% | -$145.82M-19.2% | -$148.25M-23.5% | -$135.34M-11.9% | ||
| $4.07M-37.3% | $4.07M-46.5% | $4.17M-49.2% | $5.42M-30.2% | $6.5M-5.9% | ||
| $564K— | $36K— | —— | —— | —— | ||
| -$115.41M+19.5% | -$109.01M+23.8% | -$107.91M+21.3% | -$154.8M-19.1% | -$143.37M-15.9% | ||
| -202.5%+147pp | -174.7%+165pp | -162.3%+154pp | -637.1%-331pp | -349.8%-17.6pp | ||
| -$117.53M+19.4% | -$111.29M+23.6% | -$110.34M+21.0% | -$157.29M-18.8% | -$145.87M-15.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Tango Therapeutics's income statement data come from?
- Every line is extracted from Tango Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.